Granulocyte-Colony Stimulating Factor Nanocarriers for Stimulation of the Immune System (Part II): Dose-Dependent Biodistribution and In Vivo Antitumor Efficacy in Combination with Rituximab - Centre de recherche en cancérologie de Lyon (UMR INSERM 1052 ; CNRS 5286 ; Centre Léon Bérard) Accéder directement au contenu
Article Dans Une Revue Bioconjugate Chemistry Année : 2018

Granulocyte-Colony Stimulating Factor Nanocarriers for Stimulation of the Immune System (Part II): Dose-Dependent Biodistribution and In Vivo Antitumor Efficacy in Combination with Rituximab

Fichier non déposé

Dates et versions

hal-01767371 , version 1 (16-04-2018)

Identifiants

Citer

David Kryza, Gabriel de Crozals, Doriane Mathé, Jacqueline Taleb Sidi-Boumedine, Marc Janier, et al.. Granulocyte-Colony Stimulating Factor Nanocarriers for Stimulation of the Immune System (Part II): Dose-Dependent Biodistribution and In Vivo Antitumor Efficacy in Combination with Rituximab. Bioconjugate Chemistry, 2018, 29 (3), pp.804 - 812. ⟨10.1021/acs.bioconjchem.7b00606⟩. ⟨hal-01767371⟩
61 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More